Minimally Invasive UroLift® System Provides Safe and Effective Symptom Relief for Men with an Enlarged Prostate While Preserving Sexual Function*
Throughout the day-and-a-half Inaugural ANZ BPH Summit, held at the
“It was fantastic to have passionate international and local urologists gather at the Inaugural ANZ BPH Summit to share their experiences, knowledge, and advancements in BPH treatment,” said
“The UroLift System was developed as an innovative solution for BPH that involves no cutting, heating or removal of tissue, in a simple procedure,” added co-founder
BPH, also known as an enlarged prostate, is non-cancerous enlargement of the prostate that occurs as men age. The condition affects over 680,000 men in the
About the UroLift® System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with an enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function.*3,4 Patients also experienced significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System worldwide. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the
About Teleflex Interventional Urology
The Teleflex Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving sexual function.*3,4 Learn more at www.NeoTract.com.
About
Contacts:
For
Treasurer and Vice President, Investor Relations
Media:
nicole@healthandcommerce.com
1 Speakman et al. 2014
2 Tubaro et al. 2003 Drugs Aging
3 Roehrborn, J Urology 2013 LIFT Study
4 Shore, Can
*No instances of new, sustained erectile or ejaculatory dysfunction
Source:
2020 GlobeNewswire, Inc., source